SCHEMBL17952995

SCHEMBL17952995

CC1=Cc2c(cccc2N2CCc3ccccc32)C1CC1C(C)=Cc2c1cccc2N1c2ccccc2CC1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 1/20 0.35
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HTT P42858 3/20 0.32
LMNA P02545 3/20 0.32
MAPT P10636 1/20 0.32
SRD5A1 P18405 2/20 0.32
HSD17B10 Q99714 3/20 0.31
PKM P14618 1/20 0.31
CLK1 P49759 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
NOTUM Q6P988 1/20 0.31
KDM4E B2RXH2 2/20 0.31
HPGD P15428 2/20 0.31
MEN1 O00255 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17952988 0.94 ROCK1 (0.34) ROCK1ALDH1A1HTTLMNAMAPT
SCHEMBL17952996 0.92 CHRM2 (0.34) ALDH1A1SMN1; SMN2HTTSRD5A1HSD17B10
SCHEMBL17169027 0.90 ROCK1 (0.39) ROCK1ALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL17169024 0.89 SMN1; SMN2 (0.39) ROCK1ALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL17952991 0.88 ROCK1 (0.35) ROCK1ALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL17952989 0.86 CHRM2 (0.35) ROCK1ALDH1A1CHRM2CHRM4CHRM1
SCHEMBL17952987 0.85 JAK2 (0.38) ROCK1ALDH1A1SMN1; SMN2MAPTSRD5A1
SCHEMBL17169026 0.83 L3MBTL1 (0.37) SMN1; SMN2LMNAMAPTCHRM2CHRM4
SCHEMBL17169025 0.82 MEN1 (0.38) ROCK1ALDH1A1SMN1; SMN2MAPTSRD5A1
SCHEMBL17952992 0.82 ALDH1A1 (0.37) ROCK1ALDH1A1HTTLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790240-B2 Ligand compound, a preparation method thereof, a transition metal compound, and a preparation method thereof LG CHEM, LTD. (KR) 2017-10-17 US disclosed
US-20160215004-A1 A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND, AND A PREPARATION METHOD THEREOF LG CHEM, LTD. (KR) 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160215004-A1 A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND, AND A PREPARATION METHOD THEREOF CD40LG, OSTC, TNFSF10 ROCK1 3232/4885ALDH1A1 2895/4885SMN1; SMN2 4715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.